blaVIM- and blaOXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda

Table 5 Susceptibility profiles of CRAB and CRPA positive for bla_VIM plus class 1 integrons

Isolate No.	Year of isolation	Carbapenem resistant Acinetobacter baumanii
Isolate No.	Year of isolation	IMP	MEM	CN	PTZ	CAZ	AK	FEP	CIP	CT
4268^a	2015	R	R	R	R	R	R	R	R	S
2932^a	2015	R	R	R	R	R	R	S	R	S
4643^a	2015	R	R	R	I	R	S	I	R	S
1566.3^a	2015	R	R	S	R	R	S	R	R	S
2932.2^a	2015	R	R	I	I	R	S	S	R	S
4722.1	2015	R	R	I	I	R	S	R	I	S
5730.2^a	2015	R	R	R	I	R	R	R	I	S
1566^a	2016	R	R	R	I	R	S	R	I	S
2753.1	2016	R	R	R	I	R	I	R	R	S
1688^a	2016	R	R	R	I	R	S	I	I	S
2026.2	2016	R	R	R	S	I	S	I	I	S
4264.2^a	2017	R	R	R	R	R	R	R	R	S
4264.1^a	2017	R	R	R	R	R	R	R	R	S
4725.1	2017	R	R	R	I	R	S	I	R	S
2987.1^a	2017	R	R	R	I	I	S	S	S	S
3523	2017	R	R	R	R	R	S	R	R	S
4725.2	2017	R	R	R	R	R	R	R	R	S
1314.1	2017	R	R	R	I	R	R	R	R	S
1314.2	2017	R	R	S	I	R	S	R	R	S
% R^a		100	100	82	46	91	46	55	55	0
% R		100	100	79	37	90	42	63	63	0
Carbapenem resistant Pseudomonas aeruginosa
4786	2015	R	R	R	I	R	R	R	I	S
5730^a	2015	R	R	R	I	R	R	R	I	S
3361^a	2015	R	R	R	R	R	R	R	R	S
0620^a	2015	R	R	R	I	R	S	S	I	S
6797^a	2016	R	R	R	R	R	R	I	R	S
1688.2^a	2016	R	R	R	I	R	R	R	I	S
0004.1	2017	R	R	R	R	R	R	R	I	S
3512^a	2017	R	I	R	R	S	R	R	R	S
3168	2017	R	R	R	I	R	S	R	I	S
1864	2017	R	R	R	R	R	R	I	I	S
0466.2^a	2017	R	R	R	R	R	R	R	R	S
0004.2^a	2017	R	R	R	I	R	R	R	R	S
0466.1^a	2017	R	R	R	R	R	R	R	R	S
0903^a	2017	R	R	R	R	R	S	R	R	S
3337.1^a	2017	R	R	R	R	R	R	R	R	S
3337.2^a	2017	R	R	R	R	R	R	R	R	S
0921^a	2017	R	R	R	I	I	S	S	S	S
3476	2017	R	R	R	I	R	S	S	I	S
% R^a		100	92	100	62	85	77	77	69	0
% R		100	94	100	56	89	72	72	50	0

^abla_VIM plus class 1 integron positive isolates; IMP Imipenem, MEM Meropenem, CN Gentamicin, PTZ Piperacillin/tazobactam, CAZ Ceftazidime, AK Amikacin, FEP Cefepime, CIP Ciprofloxacin, CT Colistin, R Resistant, I Intermediate, S Susceptible

ISSN: 1471-2334